Targeting Sugar Uptake and Metabolism for Cancer Identification and Therapy: An Overview

Author(s): Marina Tanasova*, Vagarshak V. Begoyan, Lukasz J. Weselinski

Journal Name: Current Topics in Medicinal Chemistry

Volume 18 , Issue 6 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Metabolic deregulations have emerged as a cancer characteristic, opening a broad avenue for strategies and tools to target cancer through sugar uptake and metabolism. High expression levels of sugar transporters in cancer cells offered glycoconjugation as an approach to achieve enhanced cellular accumulation of drugs and imaging agents, with the sugar moiety anchoring the bioactive cargo to cancer cells. On the other hand, high demand for sugar nutrients in cancers provided a new avenue to target cancer cells with metabolic or sugar uptake inhibitors to induce cancer cells starvation or death. This overview summarizes recent advances in targeting cancer cells through sugar transport for cancer detection and therapy.

Keywords: Carbohydrate Uptake, GLUTs, Glycoconjugates, Nanoparticles, Imaging Agents, Uptake Inhibitors, Drug Delivery, Cancer Imaging, Sugar-Disease Connection.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [467 - 483]
Pages: 17
DOI: 10.2174/1568026618666180523110837
Price: $65

Article Metrics

PDF: 57
HTML: 13
PRC: 1